Oncology Sesh
Capstone project exploring an accessible educational website inspired by OncologySesh, helping patients and families understand cancer science, biomarkers, and personalized care.
Sesh Incorporated describes itself as a San Diego biotechnology startup. Its RELOAD (Restriction Element Loss Of Allele Detection) blood test is designed to identify biomarkers such as HLA loss of heterozygosity (HLA LOH), helping inform immunotherapy decisions.
Why we chose this organizationOur motivation: Our team shares an interest in STEM and in making complex medical information easier to understand. OncologySesh’s focus on precision oncology inspired us to explore how an educational website could help patients and families learn about the science behind personalized cancer care.
Student capstone · In development. This project explores an accessible educational experience inspired by OncologySesh’s work in precision oncology. It is an independent student-built concept, not an official OncologySesh service, diagnostic tool, or source of medical advice. Proposed features are project ideas, not descriptions of services offered by OncologySesh.
This capstone proposes an approachable way for patients and families to explore precision oncology. Through plain-language explanations and interactive learning tools, the project aims to introduce cancer biology, biomarkers, liquid biopsies, and the role of personalized treatment.
Experience: explore → learn → interact → reflect → prepare questions
Project focus: accessible cancer education, biomarker explanations, liquid biopsy concepts, interactive activities, reading-level options, and resources for preparing questions for a care team.
Organization background
According to the official Sesh website, the organization develops cancer diagnostics. Our capstone proposes educational tools inspired by that work; the activities below are student ideas rather than official Sesh services.
Founders and leadership
Co-founder and CEO
Co-founder, Collaborations
Business Development Advisor
Published development milestones
The website does not specify a founding date. Its news documents these milestones:
- November 8, 2025: NIH SBIR research funding announced.
- December 23, 2025: Joined EvoNexus to support commercialization.
- March 17, 2026: Selected for CONNECT Cool Companies.
- May 7, 2026: Advanced to SDAC VIII’s final six.
- June 4, 2026: Announced a San Diego Angel Conference win and $200,000 investment.
- June 2026: Reported an SDIC Showcase Golden Ticket award.
Collaborators
The official site displays EvoNexus, Cleveland Clinic, University of Delaware, Providence, Frederick National Laboratory, and a logo hosted by Liga Puertorriqueña Contra el Cáncer. It does not detail each collaboration’s scope.
Source: Sesh — organization, collaborators, contact, and news, reviewed November 12, 2026. The site identifies Sesh as a startup; nonprofit status is not established there.
From problem to product direction
Terms such as biomarkers, liquid biopsy, and immunotherapy introduce complex ideas. Our design challenge is to explain these concepts without overwhelming visitors or implying that an educational website can interpret their individual medical situation.
Build an accessible educational website that pairs clear explanations with interactive activities, helping visitors explore precision oncology and prepare thoughtful questions for their healthcare team.
Proposed core features
All modules are still going through the ideation process.
Organize educational material around common questions about cancer science and personalized treatment, with clear distinctions between general information and individual medical advice.
Use matching games, short quizzes, and visual activities to reinforce concepts such as cells, biomarkers, and the immune system.
Provide introductory explanations alongside more detailed content so visitors can choose a level of scientific depth that suits their needs.
Introduce what biomarkers are and how they can inform cancer research and treatment decisions. This feature would explain concepts without calculating personal risk or recommending treatment.
Use a visual learning sequence to introduce how a blood sample can provide information about cancer-related biomarkers, while explaining that clinical testing and interpretation belong with qualified healthcare professionals.
System flow
The proposed experience connects introductory science, interactive learning, and personal reflection without providing clinical assessments.
Visitors enter through an accessible website with clearly labeled topics, plain-language introductions, and straightforward navigation.
Users explore modules, choose a reading level, complete learning activities, and identify concepts they want to understand better.
Educational modules and visual explanations introduce cancer biology, biomarkers, liquid biopsies, and personalized treatment concepts.
The experience aims to help visitors build familiarity with key terms and prepare questions to discuss with their healthcare team.
Technical foundation
Jekyll, HTML, and JavaScript provide the foundation for a responsive educational website with accessible navigation and interactive learning tools.
Python Flask services could support educational content delivery, activity responses, and future learning workflows as the project develops.
Proposed modules combine plain-language explanations, reading-level options, and interactive activities. Medical content would require appropriate sourcing and qualified review before public use.
Turn earlier project ideas into a clear, maintainable educational concept centered on precision oncology, accessibility, and responsible communication.
Our team
Our team is exploring how thoughtful design and interactive technology can make precision oncology concepts more approachable.
Product Owner
Scrum Master
System Architect
Education Liaison